Feng has 25 years of healthcare operational and investment experiences on a global basis in MedTech, pharma/biotech, and healthcare service sectors. His professional experiences include Partner at Pagoda Capital, an established global technology and healthcare investment firm headquartered in Beijing; Managing Director at Fosun Group based in New York, responsible for overseas healthcare private equity investment for one of the largest asset management firms from China; Director Corporate Business Development at Henry Schein, where he led M&A activities in Asia Pacific on behalf of one of the Fortune 500 companies in the US. He previously also had management positions with Sanofi Pasteur and R&D experiences in vaccine industry in China. Mr. Han currently is a member of the Board of Directors of Hamilton Thorne Ltd., a US public company.
Feng holds an MBA in Finance and Marketing from The Wharton School, University of Pennsylvania; a MS in Microbiology and Molecular Genetics from Michigan State University, and a BS in Microbial Engineering from Shandong University.
Feng resides in Long Island New York and is an avid skier in the winter and an enthusiastic cyclist in the summer. He enjoys reading, travel, and going on long hikes with wife and three children.
Laurel Hollow Capital
Copyright © 2024 Laurel Hollow Capital - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.